Review



neutralization experiment  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol neutralization experiment
    Neutralization Experiment, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neutralization experiment/product/TargetMol
    Average 94 stars, based on 1 article reviews
    neutralization experiment - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    94
    TargetMol neutralization experiment
    Neutralization Experiment, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neutralization experiment/product/TargetMol
    Average 94 stars, based on 1 article reviews
    neutralization experiment - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    96
    Bio X Cell ifnar1 neutralization experiment
    Fig. 5 | IFN-I signaling in T cells drives GzmB production and renal tissue damage. a CD8+ and CD4+ T cells were isolated from the spleen of <t>Ifnar1</t> KO or wild- type mice, and transferred into Rag1 KO mice (WT, n = 8; KO, n = 9). b Representative photographs of PAS staining of the kidney. Quantification is also shown (WT, n = 8; KO, n = 9). Representative histograms and bar graphs showing the MFI of IRF7 in CD8+ T cells (c) and CD4+ T cells (d) isolated from the kidney (WT, n = 8; KO, n = 9). e Representative flow cytometry plots and a bar graph illustrating the production of GzmB in CD8+ T cells (WT, n = 8; KO, n = 9). f Bar graph showing the production of GzmB in CD4+ T cells (WT, n = 8; KO, n = 9). g cGN was induced in mice, and mice were injected with anti-IFNAR1 Ab (n = 10) or isotype control (n = 9)
    Ifnar1 Neutralization Experiment, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ifnar1 neutralization experiment/product/Bio X Cell
    Average 96 stars, based on 1 article reviews
    ifnar1 neutralization experiment - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    90
    Leap Therapeutics neutralization antibodies for animal experiments igg4
    Fig. 5 | IFN-I signaling in T cells drives GzmB production and renal tissue damage. a CD8+ and CD4+ T cells were isolated from the spleen of <t>Ifnar1</t> KO or wild- type mice, and transferred into Rag1 KO mice (WT, n = 8; KO, n = 9). b Representative photographs of PAS staining of the kidney. Quantification is also shown (WT, n = 8; KO, n = 9). Representative histograms and bar graphs showing the MFI of IRF7 in CD8+ T cells (c) and CD4+ T cells (d) isolated from the kidney (WT, n = 8; KO, n = 9). e Representative flow cytometry plots and a bar graph illustrating the production of GzmB in CD8+ T cells (WT, n = 8; KO, n = 9). f Bar graph showing the production of GzmB in CD4+ T cells (WT, n = 8; KO, n = 9). g cGN was induced in mice, and mice were injected with anti-IFNAR1 Ab (n = 10) or isotype control (n = 9)
    Neutralization Antibodies For Animal Experiments Igg4, supplied by Leap Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neutralization antibodies for animal experiments igg4/product/Leap Therapeutics
    Average 90 stars, based on 1 article reviews
    neutralization antibodies for animal experiments igg4 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    94
    Proteintech neutralization antibody experiment
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    Neutralization Antibody Experiment, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neutralization antibody experiment/product/Proteintech
    Average 94 stars, based on 1 article reviews
    neutralization antibody experiment - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    91
    R&D Systems leptin neutralizing antibody nab experiment
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    Leptin Neutralizing Antibody Nab Experiment, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/leptin neutralizing antibody nab experiment/product/R&D Systems
    Average 91 stars, based on 1 article reviews
    leptin neutralizing antibody nab experiment - by Bioz Stars, 2026-06
    91/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology sub1 blocking experiments sub1 neutralization
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    Sub1 Blocking Experiments Sub1 Neutralization, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sub1 blocking experiments sub1 neutralization/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    sub1 blocking experiments sub1 neutralization - by Bioz Stars, 2026-06
    91/100 stars
      Buy from Supplier

    95
    R&D Systems Hematology g csf neutralization experiment
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    G Csf Neutralization Experiment, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/g csf neutralization experiment/product/R&D Systems Hematology
    Average 95 stars, based on 1 article reviews
    g csf neutralization experiment - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    90
    Seabright Laboratories binding and neutralization knock-out experiments
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    Binding And Neutralization Knock Out Experiments, supplied by Seabright Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/binding and neutralization knock-out experiments/product/Seabright Laboratories
    Average 90 stars, based on 1 article reviews
    binding and neutralization knock-out experiments - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    95
    R&D Systems Hematology il 6 neutralization experiment
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    Il 6 Neutralization Experiment, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 6 neutralization experiment/product/R&D Systems Hematology
    Average 95 stars, based on 1 article reviews
    il 6 neutralization experiment - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    98
    Revvity gp130 neutralization experiment
    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. <t>Neutralization</t> of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).
    Gp130 Neutralization Experiment, supplied by Revvity, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gp130 neutralization experiment/product/Revvity
    Average 98 stars, based on 1 article reviews
    gp130 neutralization experiment - by Bioz Stars, 2026-06
    98/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 5 | IFN-I signaling in T cells drives GzmB production and renal tissue damage. a CD8+ and CD4+ T cells were isolated from the spleen of Ifnar1 KO or wild- type mice, and transferred into Rag1 KO mice (WT, n = 8; KO, n = 9). b Representative photographs of PAS staining of the kidney. Quantification is also shown (WT, n = 8; KO, n = 9). Representative histograms and bar graphs showing the MFI of IRF7 in CD8+ T cells (c) and CD4+ T cells (d) isolated from the kidney (WT, n = 8; KO, n = 9). e Representative flow cytometry plots and a bar graph illustrating the production of GzmB in CD8+ T cells (WT, n = 8; KO, n = 9). f Bar graph showing the production of GzmB in CD4+ T cells (WT, n = 8; KO, n = 9). g cGN was induced in mice, and mice were injected with anti-IFNAR1 Ab (n = 10) or isotype control (n = 9)

    Journal: Nature communications

    Article Title: Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice.

    doi: 10.1038/s41467-025-59819-7

    Figure Lengend Snippet: Fig. 5 | IFN-I signaling in T cells drives GzmB production and renal tissue damage. a CD8+ and CD4+ T cells were isolated from the spleen of Ifnar1 KO or wild- type mice, and transferred into Rag1 KO mice (WT, n = 8; KO, n = 9). b Representative photographs of PAS staining of the kidney. Quantification is also shown (WT, n = 8; KO, n = 9). Representative histograms and bar graphs showing the MFI of IRF7 in CD8+ T cells (c) and CD4+ T cells (d) isolated from the kidney (WT, n = 8; KO, n = 9). e Representative flow cytometry plots and a bar graph illustrating the production of GzmB in CD8+ T cells (WT, n = 8; KO, n = 9). f Bar graph showing the production of GzmB in CD4+ T cells (WT, n = 8; KO, n = 9). g cGN was induced in mice, and mice were injected with anti-IFNAR1 Ab (n = 10) or isotype control (n = 9)

    Article Snippet: For the IFNAR1 neutralization experiment, we injected 100μg of InVivoMAb anti-mouse IFNAR-1 antibody (BioXCell, BE0241) or InVivoMAb anti-mouse IgG1 isotype control antibody (BioXCell, BE0083) on days 0, 3, 6, and 9 of the cGN.

    Techniques: Isolation, Staining, Cytometry, Injection, Control

    ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. Neutralization of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).

    Journal: Oncoimmunology

    Article Title: Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer

    doi: 10.1080/2162402X.2024.2429186

    Figure Lengend Snippet: ER+ breast cancer cell-derived S100A11 promotes monocyte recruitment in a 3D collagen matrix. (a) ELISA assay to quantify S100A11 secretion level by ER+ breast cancer cell lines. T47D cells exhibit higher S100A11 levels compared to MM330 or BT483 ( n = 2 biological replicates). (b) 3D collagen matrix experiment to quantify CD14+ monocyte recruitment by cancer cells. T47D cancer cells recruited the highest number of monocytes compared to MM330 or BT483 (biological replicates: n = 4 for T47D, BT483; n = 3 for MM330). (c) Time-lapse images of monocyte infiltration into 3D collagen matrices embedded with T47D for 24 h. Red dotted lines indicate the interface between media and collagen matrices. Orange arrows indicate the infiltrated CD14+ monocytes. Neutralization of S100A11 using a blocking antibody decreased the number of recruited monocytes. Scale bars, 100 µm. (d) Quantification of recruited CD14+ monocytes in images shown in (c) ( n = 3 biological replicates). (e) Normalized number of CD14+ monocytes that infiltrated into the collagen matrices embedded with control siRNA or S100A11 siRNA-treated T47D cells ( n = 4 biological replicates). (f) Visualization of cancer-monocyte interactions in organoids embedded in the collagen gel after 24 h under IgG control or anti-S100A11 conditions. Scale bars, 50 µm. Red: actin staining; Green: CMFDA monocyte staining; blue: nuclear staining. (G) Treatment with the S100A11 blocking antibody decreased monocyte recruitment toward breast cancer organoids in collagen matrices ( n = 3 biological replicates).

    Article Snippet: For the neutralization antibody experiment, a S100A11 blocking antibody (Proteintech, Cat# 10237–1-AP) was added at a concentration of 1 μg/ml.

    Techniques: Derivative Assay, Enzyme-linked Immunosorbent Assay, Neutralization, Blocking Assay, Control, Staining